A detailed history of Mcf Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Mcf Advisors LLC holds 41 shares of EXAS stock, worth $2,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41
Previous 41 -0.0%
Holding current value
$2,435
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$56.27 - $73.77 $9,565 - $12,540
-170 Reduced 80.57%
41 $2,000
Q4 2023

Feb 01, 2024

BUY
$59.06 - $75.72 $10,040 - $12,872
170 Added 414.63%
211 $15,000
Q1 2022

May 05, 2022

BUY
$57.56 - $82.54 $2,359 - $3,384
41 New
41 $2,000
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $2,972 - $4,127
-41 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $2,989 - $4,182
41 New
41 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mcf Advisors LLC Portfolio

Follow Mcf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.